| Quarter | Score |
|---|---|
| 2022-Q1 | 51.7 |
| 2022-Q3 | 65.5 |
| 2022-Q4 | 49.2 |
| 2023-Q1 | 49.0 |
| 2023-Q2 | 45.0 |
| 2023-Q3 | 48.7 |
| 2023-Q4 | 66.4 |
| 2024-Q1 | 60.3 |
| 2024-Q2 | 67.1 |
| 2024-Q3 | 57.4 |
| 2024-Q4 | 57.4 |
| 2025-Q1 | 58.6 |
| 2025-Q2 | 94.3 |
| 2025-Q3 | 61.4 |
| 2025-Q4 | 88.7 |
| 2026-Q1 | 76.3 |
| 2026-Q2 | 77.1 |
High consensus with active accumulation at an attractive valuation
Trading +13.5% above funds' estimated purchase price
2 of 18 tracked funds hold HSIC. Avg conviction: 0.8%. Net adding. First tracked at $74.24 (current +13.5% vs tracked).
Greenlight Capital has 1.5% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Greenlight Capital | 1.5% | Add |
| Citadel Advisors | 0.0% | Add |